Clinical Application Analysis of Adjuvant Drugs in 32 Secondary Hospitals of Xi'an During 2013 and 2015
- VernacularTitle:西安市32家二级医院2013~2015年辅助用药使用情况分析
- Author:
Haiyan LI
;
Fengyu SONG
;
Bin HU
- Keywords:
Adjuvant drugs;
Rational drug use;
Sales amount;
DDDs;
DDC;
Adverse drug reaction
- From:
China Pharmacist
2017;20(8):1445-1448
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the utilization of adjuvant drugs in the secondary hospitals from Xi'an, and to provide reference for rational use of adjuvant drugs.Methods: The utilization of adjuvant drugs of the top 20-ranked drugs in 32 secondary hospitals from Xi'an during 2013 and 2015 was analyzed statistically in respects of total consumption sum of adjuvant drugs, the proportion of adjuvant drugs sum, the consumption sum, DDDs and DDC of each adjuvant drug, and adverse drug reaction.Results: The total consumption sum and the proportion of adjuvant drugs sum increased year by year from 2013 to 2015.13 kinds of adjuvant drugs were included in top 20 in the list of total consumption sum from more than 3 hospitals in three years.Danhong injection, shuxuening injection, xueshuantong injection, xueshuantong injection, xuesaitong injection, deproteinized calf blood serum injection took up the front in the list of consumption sum and DDDs in 3 years.The cases of adjuvant drugs-induced ADR increased year by year.Conclusion: At present, adjuvant drugs become the important part of clinical drug use in this area.The consumption sum and amount is increasing rapidly.Great importance should be attached to the rational administration and safety use of the adjuvant drugs to control the unreasonable increase of drug expenses.
